脑脊液管理市场增长、规模、份额、趋势、关键参与者分析及 2030 年预测

  • Report Code : TIPRE00004182
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 177
Buy Now

Cerebrospinal Fluid Management Market Report | Size & Share 2030

Buy Now

 

[研究报告] 2022年脑脊液管理市场价值为19.1137亿美元,预计到2030年将达到28.9254亿美元。预计2022-2030年期间的复合年增长率为5.3%。

 

市场洞察和分析师观点:

由于采用微创手术来管理和治疗脑脊液 (CSF) 漏,脑脊液管理市场规模正在迅速增长。此外,市场的增长还归因于医疗器械行业的不断发展,这些发展使创新的 CSF 分流器和 CSF 引流系统得以商业化。除了不断发展的发展之外,不同地区的政府还支持使用 CSF 管理设备来解决日益严重的脑积水和其他神经系统疾病问题。  

此外,各国政府还增加了资金投入,以扩大神经系统疾病的研究和开发。例如,2022 年 5 月,美国国立卫生研究院下属的国家神经疾病和中风研究所向麦戈文医学院的一个研究团队提供了 285 万美元的五年资助。这些资金预计将用于研究脑积水婴儿的新技术。该技术将部署技术来了解脑脊液流动动力学在出血后脑积水 (PHH) 中的作用。这项研究将有助于制定预防、进展和治疗策略。新技术的商业化将在未来几年提升市场价值。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

脑脊液管理市场:

脑脊液管理市场
  • Cerebrospinal Fluid Management Market
    复合年增长率(2022 - 2030 年)
    5.3%
  • 2022 年市场规模
    19.1 亿美元
  • 2030 年市场规模
    28.9 亿美元

市场动态

增长动力
  • 脑脊液漏病例不断增加
  • CSF 管理产品的发展
未来的趋势
  • 脑脊液分流术的发展
机会
  • 越来越重视神经系统疾病中的脑脊液管理

关键人物;主力;重要一员

  •  
  • 美敦力公司
  • Integra 生命科学控股公司
  • B. Braun SE
  • Argi 集团健康服务有限公司
  • 索菲萨公司
  • 贝克史密斯医疗公司
  • 德尔塔外科有限公司
  • 莫勒医疗有限公司
  • 纳特斯医疗公司

区域概况

Cerebrospinal Fluid Management Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Cerebrospinal Fluid Management Market产品
  • 脑脊液分流术和脑脊液引流系统
Cerebrospinal Fluid Management Market最终用户
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的
Cerebrospinal Fluid Management Market地理
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

增长动力和挑战:

据《神经外科杂志》报道,全球每年估计有超过 6900 万人遭受创伤性脑损伤。东南亚和西太平洋等地区的发病率预计最高。脑损伤和脊髓损伤是成人脑脊液 (CSF) 漏出的最常见原因,需要进行脑脊液管理。高血压是成人和老年人脑脊液漏出的另一个显著原因,主要由生活方式的改变和不健康的习惯引起。同样,高血压在老年人中很常见,最终导致特发性颅内高压 (IIH) 的风险增加。因此,老年人口的增长可能与脑脊液管理市场的增长有关。

脑积水的发病率在世界范围内显著上升。老年人群中脑积水的发病率最高;值得注意的是,儿童群体中脑积水的发病率高于成年人。根据美国国家医学图书馆 (NLM) 发表的一篇文章,脑积水的全球发病率为每 100,000 人中约有 85 人。根据同一来源,儿童群体的发病率为每 100,000 人中约有 88 人,而成年人群体的发病率为每 100,000 人中约有 11 人,老年人群体的发病率为每 100,000 人中约有 175 人。此外,中低收入国家的脑积水发病率为每 100,000 新生儿中约有 123 人,而高收入国家的发病率为每 100,000 新生儿中约有 79 人。脑脊液分流和引流系统是适合所有年龄段人群脑积水病例的治疗选择。因此,脑脊液漏出病例的增加推动了脑脊液管理市场的增长。

相反,故障和制造风险是制约市场增长的重要因素。患者在放置脑脊液分流器后面临许多并发症,主要是由于可能存在故障、感染和功能不正常的风险。分流器故障的主要原因包括近端和远端导管阻塞、断开和感染。不良影响在年轻人和老年人中同样常见。脑脊液分流程序需要持续监测,并需要随访诊所和医院,因为阀门可能出现故障,这可能导致脑脊液流压变化,导致过度引流或引流不足。

 

报告细分和范围:

脑脊液管理市场份额根据产品和最终用户划分。根据产品,市场分为脑脊液分流器和脑脊液引流系统。2022 年,脑脊液分流器部分占据了更大的市场份额,预计在预测期(2022-2030 年)内将以显着的复合年增长率增长。脑脊液分流器部分进一步分为脑室腹腔分流器、脑室心房分流器、脑室胸膜分流器和腰池腹腔分流器。同样,脑脊液引流系统分为外部脑室引流 (EVD) 系统和腰椎引流 (LD) 系统。按产品划分,市场的整体增长归因于产品发布的增加、对高级脑脊液分流器的需求增加以及脑积水发病率的增加。

根据最终用户,市场分为医院、诊所、门诊手术中心和神经中心。2022 年,医院部门按最终用户占据最大的市场份额,预计未来几年将以最快的速度增长。根据地域,市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

节段分析:

根据产品,脑脊液管理市场细分为脑脊液分流器和脑脊液引流系统。脑脊液分流器部分占有较大的市场份额,预计在预测期内(2022-2030 年)将实现显着的复合年增长率。脑脊液分流器广泛用于治疗脑积水。这些分流器由硅胶管组成,可将脑脊液从脑室转移到体腔,例如腹膜、右心房或胸膜腔。脑脊液管理市场上可用的不同类型的分流器分为脑室腹腔分流器、脑室心房分流器、脑室胸膜分流器和腰池腹腔分流器。这些分流器被开发为在指定的压力水平下打开并保持打开状态,直到阀门两端的压差超过打开时的压力。

脑脊液管理市场受到全球知名和新兴企业广泛推动。2020 年 5 月,Aesculap Inc. 与 Christoph Miethke GmbH & Co. KG (MIETHKE) 联合推出了用于治疗脑积水的 M.blue 阀门。M.blue 采用重力技术,在一个阀门中集成了一个固定压差单元,从而解锁了一种简单的、依赖于位置的解决方案。因此,产品开发可能会在预测期内促进市场增长。

根据最终用户,脑脊液管理市场分为医院、诊所、门诊手术中心和神经病学中心。2022 年,医院部门按最终用户占据最大的市场份额。预计未来几年将以最快的速度增长。

 

区域分析:

根据地域,脑脊液管理市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。北美是市场增长的最大贡献者,亚太地区是增长最快的地区。北美市场的增长归因于脑积水、创伤性脑损伤和其他神经系统疾病发病率的增加、技术创新的快速发展以及医疗保健基础设施的发展等因素。根据对北美国家/地区的分析,美国是最大的市场份额持有者。根据美国国立卫生研究院 (NIH) 2023 年 3 月的最新更新,在美国,每 1,000 名婴儿中就有 2 名被诊断出患有脑积水。该国儿童脑积水的发病率与唐氏综合症一样普遍。儿童脑积水的发病率约为活产的 0.1-0.6%。儿童脑积水的发病率是导致美国对脑脊液管理设备需求增加的主要因素。2020 年 10 月发表在《美国放射学杂志》上的一篇研究文章《儿童脑积水的管理:脑脊液分流术的解剖影像学表现及其并发症》指出,脑积水影响了 1-2% 的美国人口。它导致近 70,000 人入院,每年插入 18,000-33,000 个脑脊液分流术。如此高的数据表明,该国正在经历越来越多的脑部手术,这些手术需要放置脑脊液 (CSF) 管理设备。此外,目前尚不清楚有多少人在出生后患上脑积水。随着年龄的增长,它会被诊断出来。因此,美国对脑脊液分流术的需求可能会增长。

同样,亚太地区市场的增长取决于老年人口的增长、对先进医疗设备的需求以及提供高效治疗的医疗基础设施的增加等因素。在亚太地区,中国是市场增长的最大贡献者。中国脑脊液管理市场的发展受到中国老年人中正常压力脑积水和创伤性脑损伤 (TBI) 患病率上升的推动。

 

行业发展和未来机遇:

以下列出了脑脊液管理市场主要参与者的各种举措:

  1. 2021年12月,Spiegelberg与Innovative Medcare PTY Ltd.签订合同。位于澳大利亚墨尔本的Innovative Medcare Technology PTY LTD已加入强劲发展的Spiegelberg家族。
  2. 2021 年 4 月,美敦力公司与 Surgical Theater 宣布建立合作伙伴关系,将 Surgical Theater 的 SyncAR 增强现实 (AR) 技术与美敦力的 StealthStation S8手术导航系统相结合。此次合作将使神经外科医生能够实时使用 AR 技术来增强复杂颅骨手术过程中的可视化效果。
  3. 2023 年 3 月,Möller Medical GmbH 召回了引流套件 LiquoGuard 7,因为在持续的质量和市场监控过程中,在个别案例中检测到了泄漏。

 

脑脊液管理市场报告范围

报告属性细节
2022 年市场规模19.1亿美元
2030 年的市场规模28.9亿美元
全球复合年增长率(2022 - 2030 年)5.3%
历史数据2020-2021
预测期2023-2030
涵盖的领域按产品
  • 脑脊液分流术和脑脊液引流系统
按最终用户
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 美敦力公司
  • Integra 生命科学控股公司
  • B. Braun SE
  • Argi 集团健康服务有限公司
  • 索菲萨公司
  • 贝克史密斯医疗公司
  • 德尔塔外科有限公司
  • 莫勒医疗有限公司
  • 纳特斯医疗公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

COVID-19 影响:

在 COVID-19 大流行之前,脑脊液漏的治疗程序数量相当可观。例如,在美国,从 2019 年 3 月到 2020 年 2 月,脑脊液分流手术占神经科 843 例手术的 29%。脑脊液分流手术的数量显著促进了市场的增长。此外,脑脊液分流和引流系统的需求和供应也得到了有效满足。在大流行期间,供应链中断,限制了医疗设施对多种健康状况(包括神经系统疾病)的治疗。大流行对市场产生了不利影响,并将医疗器械公司的重点转向 COVID-19 的体外诊断。即时诊断市场扩大,导致脑脊液管理市场出现负面结果。

另一方面,在 COVID-19 大流行后,脑脊液分流术和脑脊液引流术呈指数级增长,因为据报道,在许多 COVID-19 阳性病例中,急性 COVID-19 感染与神经系统有直接或间接联系。然而,关于 COVID-19 脑脊液结果的信息有限,这些信息为研发提供了机会。大流行后,人们对脑脊液分流术的认识有所提高,这极大地促进了市场增长,预计未来几年将呈现类似的趋势。通过结合数字技术来监测和控制患者的脑脊液流量,产品开发得到了加强。因此,技术进步对市场的增长做出了重大贡献。

 

竞争格局和重点公司:

脑脊液管理市场中一些知名企业包括美敦力公司 (Medtronic Plc)、Integra LifeSciences Holdings Corp、B. Braun SE、Argi Group Health Services Ltd Sti、Sophysa SA、BeckerSmith Medical Inc、Delta Surgical Ltd、Moller Medical GmbH、Natus Medical Inc 和 Spiegelberg GmbH & Co KG。这些公司专注于新产品的推出和地域扩张,以满足全球日益增长的消费者需求,并增加其专业产品组合的产品范围。它们的全球影响力使它们能够服务于大量客户,从而扩大其市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the cerebrospinal fluid management market?

Companies operating in the market are Medtronic Plc, Integra LifeSciences Holdings Corp, B. Braun SE, Argi Group Health Services Ltd Sti, Sophysa SA, BeckerSmith Medical Inc, Delta Surgical Ltd, Moller Medical GmbH, Natus Medical Inc, and Spiegelberg GmbH & Co KG.

Which end user segment held the largest revenue (US$ Mn) in the cerebrospinal fluid management market?

Based on end user, the cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers and neurological centers. In 2022, the hospitals segment held the largest share of the market, by end user. Moreover, same segment is expected to grow at the fastest rate during the coming years.

What is meant by the cerebrospinal fluid management market?

A cerebrospinal fluid leak is when the fluid surrounding your brain and spinal cord leaks out from where it’s supposed to be. If the leak is large enough, it can cause severe symptoms that make it hard or even impossible to go about your life as usual. Placement of cerebral spinal fluid (CSF) shunt systems to treat hydrocephalus is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body where the fluid is absorbed as part of the circulatory process. CSF shunts contain three main components: an in-flow tube (catheter), a valve that regulates the flow of fluid, and an outflow catheter that carries the fluid to the abdomen or the heart where the fluid can be absorbed.

What is the regional market scenario of the cerebrospinal fluid management market?

Global cerebrospinal fluid management market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the cerebrospinal fluid management market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

What are the driving factors for the cerebrospinal fluid management market across the globe?

The factors driving the market include increasing incidences of CSF leak and growing developments for CSF management products.

Which product segment led cerebrospinal fluid management market?

Based on product, the cerebrospinal fluid management market is segmented into CSF shunts and CSF drainage systems. In 2022, the CSF shunts segment held the largest share of the market by product. and the same segment is estimated to grow at a significant CAGR during the forecast period due to growing product launches, increasing demand for advanced CSF shunts, and increasing incidences of hydrocephalus.

The List of Companies - Cerebrospinal Fluid Management Market

  1. Medtronic Plc
  2. Integra LifeSciences Holdings Corp
  3. B. Braun SE
  4. Argi Group Health Services Ltd Sti
  5. Sophysa SA
  6. BeckerSmith Medical Inc
  7. Delta Surgical Ltd
  8. Moller Medical GmbH
  9. Natus Medical Inc
  10. Spiegelberg GmbH & Co KG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..